The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
Open Access
- 7 September 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (661) , eabm7621
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus driving the ongoing coronavirus disease 2019 (COVID-19) pandemic, continues to rapidly evolve. Because of the limited efficacy of vaccination in prevention of SARS-CoV-2 transmission and continuous emergence of variants of concern (VOCs), orally bioavailable and broadly efficacious antiviral drugs are urgently needed. Previously, we showed that the parent nucleoside of remdesivir, GS-441524, has potent anti–SARS-CoV-2 activity. Here, we report that esterification of the 5′-hydroxyl moieties of GS-441524 markedly improved antiviral potency. This 5′-hydroxyl-isobutyryl prodrug, ATV006, demonstrated excellent oral bioavailability in rats and cynomolgus monkeys and exhibited potent antiviral efficacy against different SARS-CoV-2 VOCs in vitro and in three mouse models. Oral administration of ATV006 reduced viral loads and alleviated lung damage when administered prophylactically and therapeutically to K18-hACE2 mice challenged with the Delta variant of SARS-CoV-2. These data indicate that ATV006 represents a promising oral antiviral drug candidate for SARS-CoV-2.Keywords
This publication has 58 references indexed in Scilit:
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesScience Translational Medicine, 2017
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesScientific Reports, 2017
- Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolutionTrends in Microbiology, 2014
- Prodrug Design Targeting Intestinal PepT1 for Improved Oral Absorption: Design and PerformanceCurrent Drug Metabolism, 2013
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosidesBioorganic & Medicinal Chemistry Letters, 2012
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- Ester Bonds in ProdrugsACS Chemical Biology, 2008
- Identification of Novel Subgenomic RNAs and Noncanonical Transcription Initiation Signals of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2005
- A Bioavailability ScoreJournal of Medicinal Chemistry, 2005
- Chemical Stability of Esters of Nicotinic Acid Intended for Pulmonary Administration by Liquid VentilationPharmaceutical Research, 2003